ArticleBrain and behavior2024

Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis.

Jannis Müller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.